MiR-106a is an independent prognostic marker in patients with glioblastoma.
Zhao S, Yang G, Mu Y, Han D, Shi C, Chen X, Deng Y, Zhang D, Wang L, Liu Y, Hou X, Wang C, Wu J, Liu H, Wang L, Zhang G, Qi J, Fang X, Shi C, Ai J.
Zhao S, et al. Among authors: wu j.
Neuro Oncol. 2013 Jun;15(6):707-17. doi: 10.1093/neuonc/not001. Epub 2013 Feb 14.
Neuro Oncol. 2013.
PMID: 23416698
Free PMC article.